A 2026 consumer warning report examining DentaBiome's oral postbiotic formula, how FabM acid-lock and 30-second kitchen ...
Researchers from Imperial and the London School of Hygiene & Tropical Medicine (LSHTM) have discovered a drug target that ...
A newly identified molecular player may help explain how cartilage in the jaw joint resists inflammatory damage.
Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a novel non-hormonal ...
A metabolic enzyme studied for over seven decades has a hidden second function - it can unwind RNA and promote cell cycle ...
Learn what vitamin B6 does in your body, including benefits for brain health, energy, immunity, heart health. Plus, the best ...
Hidden in volcanic lakes and deep-sea vents, scientists have discovered tough new DNA-binding proteins built to survive ...
Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS).
TURKU, FINLAND, March 13, 2026 / EINPresswire.com / — An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent. The study ...
Nominated KRRO-121 development candidate for the potential treatment of hyperammonemia in patients with urea cycle disorders and hepatic encephalopathyAdvanced GalNAc-conjugated oligonucleotide for ...
Gesynta Pharma has dosed the first patient in its Phase II trial, NOVA, investigating vipoglanstat, a non-hormonal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results